Telum Therapeutics Secures €18 Million Series A Financing led by AMR Action Fund and Inveready, with participation from investors Invivo Partners, CDTI, Clave Capital and Sodena

by Inveready Asset Management

Telum Therapeutics, a biotechnology company leveraging proprietary metagenomic datasets, synthetic biology and generative AI to develop novel antimicrobial therapies, has announced the successful comp...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Addleshaw Goddard delivers 17% headline ...

by Addleshaw Goddard

Addleshaw Goddard (AG), the London-headquartered international law fir...

Photos Stream